Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. rasmac

RASMAC SIGNED

Regulatory Approved Software for Mutation Analysis in Cancer

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 RASMAC project word cloud

Explore the words cloud of the RASMAC project. It provides you a very rough idea of what is the project "RASMAC" about.

positioned    healthcare    software    award    prevalence    drugs    performance    modern    lies    anti    algorithms    skilled    optimize    right    incidence    business    uppsala    uniquely    market    company    routines    worldwide    sequencing    confirmed    team    oncodia    feasibility    generation    quality    journey    expensive    disrupt    patients    standard    innovative    therapies    gap    competitiveness    rasmac    innovation    superior    technologically    cancer    regulatory    optimise    underserved    lack    makers    deterministic    diagnostic    global    accuracy    approvals    commercialisation    decision    societal    fp7    attractive    centres    approved    expertise    tumours    data    plan    budgets    university    therapy    patient    mutation    innovativeness    dna    conduct    successful    accurately    mutations    nowadays   

Project "RASMAC" data sheet

The following table provides information about the project.

Coordinator		 ONCODIA AB 

Organization address
address: C/O UU HOLDING INNOVATION HUB SCIENCE PARK
city: UPPSALA
postcode: 751 83
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Sweden [SE]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-08-01   to  2020-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ONCODIA AB SE (UPPSALA) coordinator 50˙000.00

Map

 Project objective

'As the incidence and prevalence of cancer increases worldwide, advanced anti-cancer drugs have become one of the key cost centres in healthcare budgets. This is a major societal challenge for the EU and global decision makers. Nowadays, modern anti-cancer therapies are expensive and are based on mutation analysis of cancer DNA Next-Generation-Sequencing data. However, state-of-the-art software used to analyse this data lack diagnostic accuracy and regulatory approvals.

Oncodia aims to address this market gap by developing RASMAC – software for analyses of tumours DNA sequencing data - to optimise the use of targeted anti-cancer therapies. The most innovative aspect of RASMAC lies in the deterministic algorithms that make it possible to accurately identify cancer mutations. We aim to set a new standard for diagnostic accuracy in mutation analysis in cancer that will lead to the right therapy for every patient.

Oncodia is well-positioned to disrupt the underserved market for cancer mutation analysis because of the expertise of multi-skilled team and the quality of previous projects (EU FP7 INNOVATION). Oncodia is the company able to uniquely deliver technologically superior, regulatory approved and cost-effective software. The innovativeness of our product has been recently confirmed through 'Attractive Innovation Project Award' from Uppsala University Innovation.

During the Phase 1 Project, Oncodia will develop a business plan for the development and commercialisation of RASMAC. Specific objectives of this project are to design a study to improve the performance of the product and to conduct a market feasibility assessment to optimize go-to-market plan. The Phase 1 project is an important step on Oncodia’s journey to facilitate access to better DNA-based diagnostic routines for cancer patients worldwide. If successful, the project will take Oncodia to a new level of competitiveness and growth. '

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "RASMAC" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "RASMAC" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

VINOQUANT11SUPERPLUS (2019)

A digital based system for measuring, showing and regulation of the complexe system of wine feremtation with high precision via a Bluetooth -Refractometer, a Software and a Bluetooth Thermostat

Read More  

Woodywood pickering (2019)

Bio-based (fully renewable) cost effective Polymer for new generation of ecological Coatings leveraging a disruptive innovation in the use of Pickering emulsion.

Read More